SCHEMBL4575

SCHEMBL4575

CC1COCC[N]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1609639 1.00
SCHEMBL1609662 1.00
SCHEMBL9215797 0.71
SCHEMBL4470823 0.67 NPC1 (0.31)
SCHEMBL1608730 0.67
SCHEMBL4687612 0.67
SCHEMBL4477943 0.67
SCHEMBL965233 0.67
SCHEMBL2041436 0.67
SCHEMBL1609131 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 927 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024138486-A1 TETRACYCLIC DERIVATIVES AS KRAS INHIBITORS NIKANG THERAPEUTICS, INC. (US) 2024-07-04 WO claimed
WO-2024141004-A1 COMPOUNDS AS INHIBITORS OF MACROPHAGE MIGRATION INHIBITORY FACTOR AND THE USE THEREOF NANJING IMMUNOPHAGE BIOTECH CO., LTD (CN) 2024-07-04 WO claimed
US-20240124474-A1 HER2 MUTATION INHIBITORS ARRAY BIOPHARMA INC. (US) 2024-04-18 US claimed
US-20240101553-A1 KRAS G12C INHIBITORS MIRATI THERAPEUTICS INC (US) 2024-03-28 US claimed
CN-117736375-A Double-end functional solution polymerized styrene-butadiene rubber as well as preparation method and application thereof 中国石油化工股份有限公司 2024-03-22 CN claimed
WO-2024051721-A1 TETRACYCLIC DERIVATIVES AS KRAS INHIBITORS NIKANG THERAPEUTICS, INC. (US) 2024-03-14 WO claimed
WO-2024046406-A1 ALKYLIDENE CARBAMATE AS KRAS INHIBITORS NIKANG THERAPEUTICS, INC. (US) 2024-03-07 WO claimed
WO-2024045066-A1 ALKYLIDENE CARBAMATE AS KRAS INHIBITORS NIKANG THERAPEUTICS, INC. (US) 2024-03-07 WO claimed
US-20240051975-A1 NOVEL NAMPT ENZYME AGONIST AND PREPARATION AND USE THEREOF TSINGHUA UNIVERSITY (CN) 2024-02-15 US claimed
US-20240043435-A1 TYK-2 INHIBITOR BEONE MEDICINES I GMBH (CH) 2024-02-08 US claimed
WO-2006066197-A1 TETRAHYDROISOQUINOLINE COMPOUNDS FOR TREATMENT OF CNS DISORDERS JANSSEN PHARMACEUTICA, N.V. (BE) 2006-06-22 WO claimed
EP-1485167-A1 1,2-DIHYDROPYRAZOL-3-ONES AS CYTOKINE MEDIATORS The Procter & Gamble Company (US) 2004-12-15 EP claimed
WO-2003080184-A1 1,2-DIHYDROPYRAZOL-3-ONES AS CYTOKINE MEDIATORS THE PROCTER & GAMBLE COMPANY (US) 2003-10-02 WO claimed
EP-0941994-B1 Pyrazolopyrimidines and pyrazolotriazines with 5-HT6 receptor affinity HOFFMANN LA ROCHE (CH) 2003-05-14 EP claimed
CN-1373751-A 'Alpha'-amino-'beta'-sulfonyl hydroxamic acid compounds SEARLE & CO (US) 2002-10-09 CN claimed
EP-0582789-B1 Novel 7-(substituted)-8-(substituted)-9-(substituted glycyl)amido-6-demethyl-6-deoxytetracyclines AMERICAN CYANAMID CO (US) 2001-10-04 EP claimed
EP-0582829-B1 9-[(substituted glycyl)amido]-6-demethyl-6-deoxytetracyclines as antibiotic agents AMERICAN CYANAMID CO (US) 2001-09-12 EP claimed
US-6194410-B1 ANTISEROTONINE AGENTS; NERVOUS SYSTEM AND PSYCHOLOGICAL DISORDERS HOFFMAN-LA ROCHE INC. 2001-02-27 US claimed
EP-0941994-A1 Pyrazolopyrimidines and pyrazolotriazines with 5-HT6 receptor affinity F. HOFFMANN-LA ROCHE AG (CH) 1999-09-15 EP claimed
US-4758564-A Ether and thioether amines and their use as fungicides BASF AKTIENGESELLSCHAFT (DE) 1988-07-19 US claimed